Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pegah Khosravian, Mehdi Shafiee Ardestani, Mehdi Khoobi, Seyed Naser Ostad, Farid Abedin Dorkoosh, Hamid Akbari Javar & Massoud Amanlou. (2016) Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel. OncoTargets and Therapy 9, pages 7315-7330.
Read now
Read now
Si Sun, Lichen Tang, Jian Zhang, Fangfang Lv, Zhonghua Wang, Leiping Wang, Qunling Zhang, Chunlei Zheng, Lixin Qiu, Zhen Jia, Yunhua Lu, Guangyu Liu, Zhimin Shao, Biyun Wang & Xichun Hu. (2014) Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer. International Journal of Nanomedicine 9, pages 1443-1452.
Read now
Read now
Articles from other publishers (54)
James P. Pham, Anthony M. Joshua, Ines P. da Silva, Reinhard Dummer & Simone M. Goldinger. (2023) Chemotherapy in Cutaneous Melanoma: Is There Still a Role?. Current Oncology Reports 25:6, pages 609-621.
Crossref
Crossref
Sofie Seghers, Laure-Anne Teuwen, Michiel Beyens, Dennis De Blick, Vito Sabato, Didier G. Ebo & Hans Prenen. (2023) Immediate hypersensitivity reactions to antineoplastic agents – A practical guide for the oncologist. Cancer Treatment Reviews 116, pages 102559.
Crossref
Crossref
Mikhail Khorenko, Juliana Pfeifer, Joanna Napp, Anna Meschkov, Frauke Alves, Ute Schepers & Claus Feldmann. (2023) Theranostic inorganic–organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs. Journal of Materials Chemistry B 11:16, pages 3635-3649.
Crossref
Crossref
Jeong-Hyeon Lim, Minjae Park, Yuri Park, Seo-Jin Park, Jiyu Lee, Sangsoo Hwang, Jeongmin Lee, Yujin Lee, Eunjeong Jo & Young G. Shin. (2023) Evaluation of In Vivo Prepared Albumin-Drug Conjugate Using Immunoprecipitation Linked LC-MS Assay and Its Application to Mouse Pharmacokinetic Study. Molecules 28:7, pages 3223.
Crossref
Crossref
Dan Yang, Yuqi Feng, Xiaolin Yao, Baofu Zhao, Dan Li, Ning Liu, Yapeng Fang, Adam Midgley, Dechun Liu & Nishinari Katsuyoshi. (2022) Recent advances in bioactive nanocrystal‐stabilized Pickering emulsions: Fabrication, characterization, and biological assessment. Comprehensive Reviews in Food Science and Food Safety 22:2, pages 946-970.
Crossref
Crossref
Huan Wang, Lingyun Fan, Xia Wu & Yimin Han. (2022) Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer. BMC Women's Health 22:1.
Crossref
Crossref
Juanjuan Yang, Xiaojin Wang, Bingshun Wang, Kinam Park, Karen Wooley & Shiyi Zhang. (2022) Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. Advanced Drug Delivery Reviews 190, pages 114525.
Crossref
Crossref
Yifei Cao, Yuhan Yang, Shun Feng & Yu Wan. (2022) Biomimetic cancer cell-coated albumin nanoparticles for enhanced colloidal stability and homotypic targeting of breast cancer cells. Journal of Drug Delivery Science and Technology 75, pages 103698.
Crossref
Crossref
Xinye Qian, Wang Hu & Jun Yan. (2022) Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?. Frontiers in Immunology 13.
Crossref
Crossref
Fei He, Jiaxuan Liu, Xin Shen, Zijing Wang, Qiao Li & Guohui Li. (2021) Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Annals of Pharmacotherapy 56:8, pages 898-909.
Crossref
Crossref
Yanqin Lu, Yiming Yang, Xiaohui Liu, Ning Li, Fen Hu, Bolin Zhang, Hao Dai, Haifeng Cai & Yan Jinyin Yan. (2022) Poly-2-oxazoline nanoparticles potentiate effectiveness of vismodegib for breast cancer through improvement in pharmacokinetics and reduction in systemic toxicity. Materials Express 12:8, pages 1020-1026.
Crossref
Crossref
Sheema Hashem, Tayyiba Akbar Ali, Sabah Akhtar, Sabah Nisar, Geetanjali Sageena, Shahid Ali, Sharefa Al-Mannai, Lubna Therachiyil, Rashid Mir, Imadeldin Elfaki, Mohammad Muzaffar Mir, Farrukh Jamal, Tariq Masoodi, Shahab Uddin, Mayank Singh, Mohammad Haris, Muzafar Macha & Ajaz A. Bhat. (2022) Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy 150, pages 113054.
Crossref
Crossref
Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim & Seock-Ah Im. (2022) A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer. Cancer Research and Treatment 54:2, pages 488-496.
Crossref
Crossref
Mitsuru Otsubo, Reiko Kinouchi, Takayuki Kamiya & Akitoshi Yoshida. (2021) Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports. Journal of Medical Case Reports 15:1.
Crossref
Crossref
Ana Latorre, Alfonso Latorre, Milagros Castellanos, Nuria Lafuente-Gómez, Ciro Rodriguez Diaz, Alejandra Crespo-Barreda, Mercedes Lecea, Marco Cordani, Pilar Martín-Duque & Álvaro Somoza. (2021) Albumin-based nanostructures for uveal melanoma treatment. Nanomedicine: Nanotechnology, Biology and Medicine 35, pages 102391.
Crossref
Crossref
Chieh-Ting Fang, Hsiao-Hui Kuo, Chia-Jung Yuan, Jhong-Syuan Yao & Ling-Huei Yih. (2021) Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells. Cell Death Discovery 7:1.
Crossref
Crossref
Duhyeong Hwang, Taylor Dismuke, Andrey Tikunov, Elias P. Rosen, John R. Kagel, Jacob D. Ramsey, Chaemin Lim, William Zamboni, Alexander V. Kabanov, Timothy R. Gershon & Marina Sokolsky-Papkov PhD. (2021) Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity. Nanomedicine: Nanotechnology, Biology and Medicine 32, pages 102345.
Crossref
Crossref
Alessandro Allegra, Eleonora Di Salvo, Marco Casciaro, Caterina Musolino, Giovanni Pioggia & Sebastiano Gangemi. (2020) The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients. Biomedicines 9:1, pages 2.
Crossref
Crossref
Jinjoo Kim, Juncheol Lee, Jimin Lee, Hyeongseop Keum, Yumi Kim, Yujin Kim, Byeongjun Yu, Sang Yeop Lee, Junichi Tanaka, Sangyong Jon & Myung Chul Choi. (2020) Tubulin‐Based Nanotubes as Delivery Platform for Microtubule‐Targeting Agents. Advanced Materials 32:33.
Crossref
Crossref
Tian'e Chen, Liangxing Tu, Ge Wang, Na Qi, Wei Wu, Wei Zhang & Jianfang Feng. (2020) Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy. International Journal of Pharmaceutics 578, pages 119105.
Crossref
Crossref
Ayako Kanai, Keely May McNamara, Erina Iwabuchi, Yasuhiro Miki, Yoshiaki Onodera, Fouzia Guestini, Freeha Khalid, Yasuaki Sagara, Yasuyo Ohi, Yoshiaki Rai, Rin Yamaguchi, Maki Tanaka, Minoru Miyashita, Takanori Ishida & Hironobu Sasano. (2020) Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling. Breast Cancer Research and Treatment 180:1, pages 97-110.
Crossref
Crossref
Tala M. Abu Samaan, Marek Samec, Alena Liskova, Peter Kubatka & Dietrich Büsselberg. (2019) Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 9:12, pages 789.
Crossref
Crossref
Olga Kutova, Evgenii Guryev, Evgeniya Sokolova, Razan Alzeibak & Irina Balalaeva. (2019) Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency. Cancers 11:1, pages 68.
Crossref
Crossref
Paola De Cicco, Elisabetta Panza, Chiara Armogida, Giuseppe Ercolano, Giuseppe Cirino & Angela Ianaro. 2018. Anticancer plants: Properties and Application. Anticancer plants: Properties and Application
1
36
.
Hong Su, Yafei Wang, Yuanliang Gu, Linda Bowman, Jinshun Zhao & Min Ding. (2018) Potential applications and human biosafety of nanomaterials used in nanomedicine. Journal of Applied Toxicology 38:1, pages 3-24.
Crossref
Crossref
Matthieu Picard. (2017) Management of Hypersensitivity Reactions to Taxanes. Immunology and Allergy Clinics of North America 37:4, pages 679-693.
Crossref
Crossref
Mariana S. Oliveira, Livia P. Mendes & Vladmir P. Torchilin. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy
455
484
.
Shigeru Tsuyuki, Noriko Senda, Yookija Kanng, Ayane Yamaguchi, Hiroshi Yoshibayashi, Yuichiro Kikawa, Nobuyuki Katakami, Hironori Kato, Takashi Hashimoto, Toshitaka Okuno, Akira Yamauchi & Takashi Inamoto. (2016) Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Research and Treatment 160:1, pages 61-67.
Crossref
Crossref
Zhijian He, Xiaomeng Wan, Anita Schulz, Herdis Bludau, Marina A. Dobrovolskaia, Stephan T. Stern, Stephanie A. Montgomery, Hong Yuan, Zibo Li, Daria Alakhova, Marina Sokolsky, David B. Darr, Charles M. Perou, Rainer Jordan, Robert Luxenhofer & Alexander V. Kabanov. (2016) A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101, pages 296-309.
Crossref
Crossref
Elizabeth Park, Naomi R. Goldberg & Sylvia Adams. (2016) Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy. Anti-Cancer Drugs 27:6, pages 580-584.
Crossref
Crossref
Matthieu Picard, Leyla Pur, Joana Caiado, Pedro Giavina-Bianchi, Violeta Regnier Galvão, Suzanne T. Berlin, Susana M. Campos, Ursula A. Matulonis & Mariana C. Castells. (2016) Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions. Journal of Allergy and Clinical Immunology 137:4, pages 1154-1164.e12.
Crossref
Crossref
Chris Twelves, Maria Jove, Andrea Gombos & Ahmad Awada. (2016) Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer. Critical Reviews in Oncology/Hematology 100, pages 74-87.
Crossref
Crossref
Masami Ukawa, Hidenori Ando, Taro Shimizu & Tatsuhiro Ishida. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology
219
238
.
Jasmine M. Miller-Kleinhenz, Erica N. Bozeman & Lily Yang. (2015) Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7:6, pages 797-816.
Crossref
Crossref
Matthieu Picard & Mariana C. Castells. (2014) Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review. Clinical Reviews in Allergy & Immunology 49:2, pages 177-191.
Crossref
Crossref
Sophie Marchal, Amélie El Hor, Marie Millard, Véronique Gillon & Lina Bezdetnaya. (2015) Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics. Drugs 75:14, pages 1601-1611.
Crossref
Crossref
Yuko Tanaka, Hiroko Bando, Hisato Hara, Yasuaki Ito & Yoshifumi Okamoto. (2012) Cystoid macular edema induced by nab-paclitaxel. Breast Cancer 22:3, pages 324-326.
Crossref
Crossref
Beatriz Cirauqui Cirauqui, Vanesa Quiroga García, Clara Lezcano Rubio, Maria Iciar Pascual Miguel, Laia Capdevila Riera, Nuria Pardo Aranda, Sara Vizcaya Martín, Antonio Mariscal Martínez, Clara Rodríguez Caruncho & Mireia Margelí Vila. (2014) Nanoparticle albumin-bound paclitaxel in a patient with locally advanced breast cancer and taxane-induced skin toxicity: a case report. Journal of Medical Case Reports 8:1.
Crossref
Crossref
Joana Caiado & Matthieu Picard. (2014) Diagnostic Tools for Hypersensitivity to Platinum Drugs and Taxanes: Skin Testing, Specific IgE, and Mast Cell/Basophil Mediators. Current Allergy and Asthma Reports 14:8.
Crossref
Crossref
Elvin Blanco & Mauro Ferrari. (2014) Emerging nanotherapeutic strategies in breast cancer. The Breast 23:1, pages 10-18.
Crossref
Crossref
K. N Srinivasan, Amit Rauthan & R. Gopal. (2014) Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer. Case Reports in Oncological Medicine 2014, pages 1-5.
Crossref
Crossref
Ana Lluch, Isabel Álvarez, Montserrat Muñoz, Miguel Ángel Seguí, Ignasi Tusquets & Laura García-Estévez. (2014) Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors. Critical Reviews in Oncology/Hematology 89:1, pages 62-72.
Crossref
Crossref
Li Chen Tang, Bi Yun Wang, Si Sun, Jian Zhang, Zhen Jia, Yun Hua Lu, Geng Hong Di, Zhi Ming Shao & Xi Chun Hu. (2013) Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients. BMC Cancer 13:1.
Crossref
Crossref
Raphaelle Fanciullino, Joseph Ciccolini & Gérard Milano. (2013) Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs. Critical Reviews in Oncology/Hematology 88:3, pages 504-513.
Crossref
Crossref
Simona Mura, Fatima Zouhiri, Stephanie Lerondel, Andrei Maksimenko, Julie Mougin, Claire Gueutin, Davide Brambilla, Joachim Caron, Eric Sliwinski, Alain LePape, Didier Desmaele & Patrick Couvreur. (2013) Novel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery. Bioconjugate Chemistry 24:11, pages 1840-1849.
Crossref
Crossref
James B DelehantyJoyce C Breger, Kelly Boeneman Gemmill, Michael H Stewart & Igor L Medintz. (2013) Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery. Therapeutic Delivery 4:11, pages 1411-1429.
Crossref
Crossref
Matthias Wacker. (2013) Nanocarriers for intravenous injection—The long hard road to the market. International Journal of Pharmaceutics 457:1, pages 50-62.
Crossref
Crossref
KOSEI KIMURA, SATORU TANAKA, MITSUHIKO IWAMOTO, HIROYA FUJIOKA, YUKO TAKAHASHI, NAYUKO SATO, RISA TERASAWA, TOMO TOMINAGA, AYANA IKARI & KAZUHISA UCHIYAMA. (2013) Safety of nanoparticle albumin-bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: Four case reports. Oncology Letters 6:4, pages 881-884.
Crossref
Crossref
Guido Bocci, Antonello Di Paolo & Romano Danesi. (2013) The pharmacological bases of the antiangiogenic activity of paclitaxel. Angiogenesis 16:3, pages 481-492.
Crossref
Crossref
Venkat Ratnam Devadasu, Vivekanand Bhardwaj & M. N. V. Ravi Kumar. (2012) Can Controversial Nanotechnology Promise Drug Delivery?. Chemical Reviews 113:3, pages 1686-1735.
Crossref
Crossref
Takuya Iwamoto. (2013) Clinical Application of Drug Delivery Systems in Cancer Chemotherapy: Review of the Efficacy and Side Effects of Approved Drugs. Biological and Pharmaceutical Bulletin 36:5, pages 715-718.
Crossref
Crossref
Yuzhou Wu, Er Kai Shih, Arvind Ramanathan, Subhash Vasudevan & Tanja Weil. (2012) Nano-Sized Albumin-Copolymer Micelles for Efficient Doxorubicin Delivery. Biointerphases 7:1.
Crossref
Crossref
Lisa Zimmer, Julia Vaubel, Elisabeth Livingstone & Dirk Schadendorf. (2012) Side effects of systemic oncological therapies in dermatology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 10:7, pages 475-486.
Crossref
Crossref
Yasar Akdogan, Yuzhou Wu, Klaus Eisele, Manuela Schaz, Tanja Weil & Dariush Hinderberger. (2012) Host–guest interactions in polycationic human serum albumin bioconjugates. Soft Matter 8:43, pages 11106.
Crossref
Crossref